Barcelona hospital tests new drug for end-stage renal disease patients

Barcelona's Vall d'Hebron hospital tested the efficacy of a drug on end-stage renal disease patients with hyperactivated immune systems. Imlifidase can eliminate antibodies and help prevent organ rejection in patients who would otherwise remain on dialysis for years.

ACN | Barcelona

August 25, 2022 04:39 PM

September 19, 2022 08:14 PM